BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Join SI Premium – FREE
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Smith Says Starboard Has Taken A Position In Shake Shack - Bloomberg
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- Avnet (AVT) Tops Q4 EPS by 61c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
